Join BIOCYTOGEN at BioSpark Annual Meeting

We are excited to announce that we will be exhibiting at the BioSpark Annual Meeting 2024 in Cambridge, Massachusetts, on September 14th! This prestigious event gathers basic and clinical scientists from around the globe who share a deep passion for innovation in biotechnology. It’s a fantastic opportunity to connect with like-minded professionals and gain insights from top industry leaders.

What is the BioSpark Annual Meeting?

The  BioSpark annual meeting gathering 200-300 (local) and >10,000 (online) industry leaders, researchers, investors, and entrepreneurs from the global biotechnology sector is filled with exciting talks, interactive panel discussions, and networking opportunities. This conference brings together professionals from the biotech industry to discuss the latest trends and September innovations. Whether you’re a seasoned expert or just starting out in the field, this event is perfect for anyone looking to stay ahead in the world of biotechnology. 

Event Overview  

Venue: MIT Stata Center, Cambridge, MA

Date: September 14th 9:00am-5:00pm

Event Schedule

The BioSpark Annual Meeting in Cambridge will showcase a diverse array of speakers and topics. For a comprehensive look at the daily schedule, including session times and detailed information on each presentation, please refer to the BioSpark Annual Meeting agenda.

About BIOCYTOGEN

Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

We look forward to seeing you at the BioSpark Annual Meeting 2024 in Cambridge!